Table 4.
Response to final minute of constant-workload exercise for COPD and Healthy Control groups
COPD | ||||||
---|---|---|---|---|---|---|
Ctrl | PAV | He:21% O2 | 60% O2 | He:40% O2 | Healthy Ctrl | |
Absolute power output, W | 62 ± 7 | 62 ± 7 | 62 ± 7 | 62 ± 7 | 62 ± 7 | 124 ± 6* |
Relative power output, % of peak | 52 ± 2 | 52 ± 2 | 52 ± 2 | 52 ± 2 | 52 ± 2 | 52 ± 0 |
Exercise time, min | 9.8 ± 1.2 | 9.8 ± 1.2 | 9.8 ± 1.2 | 9.8 ± 1.2 | 9.8 ± 1.2 | 14.7 ± 0.0* |
Apparatus resistance, cmH2O•l−1•s | 0.92 ± 0.12 | 0.37 ± 0.03* | 0.75 ± 0.06 | 0.99 ± 0.09 | 0.86 ± 0.09 | 1.08 ± 0.07 |
Wr-insp, cmH2O•s•min−1 | 302 ± 37 | 127 ± 20*† | 248 ± 37* | 254 ± 36* | 224 ± 31* | 208 ± 18* |
Wr-exp, cmH2O•s•min−1 | 635 ± 58 | 413 ± 25*† | 454 ± 51*† | 489 ± 45*† | 399 ± 51*† | 172 ± 15* |
SpO2, % | 86.4 ± 2.8 | 91.0 ± 1.7*† | 89.7 ± 2.4*† | 99.8 ± 0.4*† | 99.1 ± 0.4*† | 96.4 ± 0.5* |
Heart rate, beats/min | 125 ± 7 | 126 ± 4 | 121 ± 6 | 109 ± 7*† | 113 ± 5* | 126 ± 8 |
RPE (dyspnea) | 8.6 ± 0.5 | 4.9 ± 0.7* | 5.9 ± 0.7* | 4.9 ± 0.5* | 5.3 ± 0.6* | 4.1 ± 0.6* |
RPE (limb) | 8.8 ± 0.5 | 5.4 ± 0.6* | 6.1 ± 0.8* | 5.4 ± 0.6* | 5.8 ± 0.6* | 4.4 ± 0.5* |
Ti, s | 0.63 ± 0.06 | 0.65 ± 0.05 | 0.68 ± 0.05 | 0.77 ± 0.06* | 0.73 ± 0.06 | 1.05 ± 0.07* |
Te, s | 0.98 ± 0.12 | 1.20 ± 0.13* | 1.19 ± 0.09* | 1.27 ± 0.08* | 1.24 ± 0.07* | 1.28 ± 0.08* |
Ti/Ttot | 0.40 ± 0.03 | 0.36 ± 0.03† | 0.37 ± 0.02† | 0.38 ± 0.02† | 0.40 ± 0.03 | 0.45 ± 0.01 |
Vt, l | 1.70 ± 0.19 | 2.31 ± 0.25* | 1.81 ± 0.17*† | 1.61 ± 0.18† | 1.64 ± 0.17† | 2.41 ± 0.08* |
fR, breaths/min | 35.1 ± 3.0 | 33.7 ± 3.7† | 32.9 ± 2.7† | 30.1 ± 2.4* | 31.6 ± 2.6* | 26.5 ± 1.3* |
V̇e, l/min | 58.9 ± 4.9 | 77.8 ± 9.9*† | 60.2 ± 6.5 | 48.5 ± 4.2*† | 52.4 ± 4.8*† | 64.8 ± 3.1* |
V̇o2, l/min | 1.35 ± 0.18 | 1.36 ± 0.16† | 1.38 ± 0.20† | 1.68 ± 0.12*† | 2.14 ± 0.06* | |
V̇co2, l/min | 1.37 ± 0.16 | 1.33 ± 0.14† | 1.31 ± 0.19† | 1.31 ± 0.14† | 1.37 ± 0.16† | 1.97 ± 0.05 |
V̇e/V̇o2 | 44.2 ± 4.4 | 57.2 ± 5.6*† | 43.6 ± 2.1† | 31.0 ± 1.5* | 30.2 ± 0.8* | |
V̇e/V̇co2 | 42.6 ± 2.9 | 58.5 ± 3.6*† | 45.7 ± 3.9*† | 37.1 ± 1.5 | 38.1 ± 1.4 | 32.9 ± 1.3* |
ICdyn, litersa | 2.29 ± 0.14 | b | 2.65 ± 0.13*† | 2.60 ± 0.19*† | 2.64 ± 0.10*† | 3.72 ± 0.25* |
IRV, litersa | 0.63 ± 0.10 | b | 0.90 ± 0.11*† | 1.00 ± 0.14*† | 1.05 ± 0.18*† | 1.39 ± 0.14* |
ERV, litersa | 2.31 ± 0.31 | b | 1.86 ± 0.31*† | 1.98 ± 0.20† | 1.92 ± 0.31*† | 0.92 ± 0.36* |
EILV, %TLCa | 90.0 ± 1.5 | b | 86.3 ± 1.8*† | 85.6 ± 2.0* | 83.5 ± 2.9* | 81.2 ± 1.8* |
EELV, %TLCa | 68.8 ± 2.1 | b | 62.3 ± 2.3*† | 64.4 ± 2.6† | 63.2 ± 2.0*† | 49.5 ± 1.8* |
Values represent means ± SE. PAV, proportional assist ventilation; Wr-insp and Wr-exp inspiratory and expiratory muscle work, respectively; RPE, rating of perceived exertion; Ti, inspiratory time; Te, expiratory time; Ttot, total time; Vt, tidal volume; fR, respiratory frequency; V̇co2, CO2 production; ICdyn, dynamic inspiratory capacity; IRV, inspiratory reserve volume; ERV, expiratory reserve volume; EILV, end-inspiratory lung volume; EELV, end-expiratory lung volume.
P < 0.05 vs. COPD-Ctrl;
P < 0.05 vs. Healthy.
n = 6;
IC maneuvers are not feasible during exercise with PAV. See text for description of COPD interventional trials.